title: Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy.
abstract: The objective is to evaluate resistance between community-acquired urinary tract infections (CAUTI), nosocomialy-acquired urinary tract infections (NAUTI), and empirical therapy adequacy. E. coli is the predominant pathogen of both CAUTI and NAUTI, followed by Klebsiella spp. in NAUTI and Pseudomonas spp. in catheter-associated urinary tract infections. The highest level of general resistance was found among isolates of NAUTI and catheter-associated UTI followed by CAUTI isolates. Absolute or high level resistance for commonly used empirical antimicrobial therapy was found in catheter-associated UTI and NAUTI while resistance among CAUTI was respectable. Patients with NAUTI as well as patients with catheter-associated urinary tract infections have similar resistance and similar microorganisms isolated as a causative agents, and should not be empirically treated unless the clinical emergency requests.
authors.affiliation: Clinic of Urology, Clinical Center Nis, Nis, Serbia. pota@medianis.net
authors.forename: Potic B
authors.initials: PB
authors.lastname: Milan
authors.forename: Ignjatovic M
authors.initials: IM
authors.lastname: Ivan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D055499:Catheter-Related Infections / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents
references.citation: N Engl J Med. 2003 Feb 13;348(7):651-6
references.pmid: 12584377
references.citation: J Clin Microbiol. 2005 Aug;43(8):4218-20
references.pmid: 16081983
references.citation: Scand J Prim Health Care. 2000 Mar;18(1):35-8
references.pmid: 10811041
references.citation: J Antimicrob Chemother. 2003 Apr;51(4):963-70
references.pmid: 12654756
references.citation: Eur Urol. 2002 May;41(5):483-9
references.pmid: 12074789
references.citation: Jpn J Infect Dis. 2005 Jun;58(3):159-61
references.pmid: 15973007
references.citation: Int Urol Nephrol. 2002;34(2):199-202
references.pmid: 12775094
references.citation: Clin Microbiol Infect. 2001 Oct;7(10):523-31
references.pmid: 11683792
references.citation: Emerg Infect Dis. 2001 Mar-Apr;7(2):342-7
references.pmid: 11294737
references.citation: Ann Surg. 2005 Sep;242(3):326-41; discussion 341-3
references.pmid: 16135919
references.citation: Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S78-81
references.pmid: 16829053
references.citation: Eur Urol. 2007 Jan;51(1):247-53; discussion 253-4
references.pmid: 16781811
references.citation: Eur Urol. 2006 Feb;49(2):235-44
references.pmid: 16413668
references.citation: J Urol. 2005 Jan;173(1):21-6
references.pmid: 15592018
references.citation: Int Urol Nephrol. 2007;39(1):95-8
references.pmid: 17171409
references.citation: Eur Urol. 2007 Apr;51(4):1100-11; discussion 1112
references.pmid: 17049419
references.citation: Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S86-90
references.pmid: 16829050
references.citation: J Gen Intern Med. 1999 Oct;14(10):606-9
references.pmid: 10571705
references.citation: J Hosp Infect. 1998 Jan;38(1):37-49
references.pmid: 9513067
references.citation: Int Urol Nephrol. 2004;36(3):457-63
references.pmid: 15783124
references.citation: Int J Antimicrob Agents. 2001 Apr;17(4):299-303
references.pmid: 11295412